[HTML][HTML] The subdued post-boost spike-directed secondary igG antibody response in Ugandan recipients of the pfizer-bioNTech BNT162b2 vaccine has implications …
V Ankunda, JS Katende, GK Oluka, J Sembera… - Frontiers in …, 2024 - frontiersin.org
Introduction This study aimed to delineate longitudinal antibody responses to the Pfizer-
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
[HTML][HTML] Immunogenetics special issue 2023: Immunogenetics of infectious disease
PJ Norman - Immunogenetics, 2023 - Springer
The evolution of diversity in the face of pathogen challenge forms the very core of
immunogenetics. Immunity to infection is driven by multiple host genetic factors and their …
immunogenetics. Immunity to infection is driven by multiple host genetic factors and their …
[PDF][PDF] Violet Ankunda1, Joseph Ssebwana Katende1, 2, Gerald Kevin Oluka1, 2, Jackson Sembera1, Claire Baine1, Geoffrey Odoch2, Peter Ejou2, Laban Kato2, and …
AJ Auguste, A Vijayan, JT Gordy, J Serwanga - 2024 - scienceopen.com
Methods: We enrolled 48 participants and collected 320 specimens over 12 months after the
primary vaccination dose. A validated enzyme-linked immunosorbent assay (ELISA) was …
primary vaccination dose. A validated enzyme-linked immunosorbent assay (ELISA) was …
The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies
J Serwanga, V Ankunda, JS Katende, J Sembera… - 2023 - preprints.org
This study aimed to delineate the longitudinal antibody responses to the Pfizer-BioNTech
COVID-19 vaccine (BNT162b2) within the Ugandan subset of the Sub-Saharan African …
COVID-19 vaccine (BNT162b2) within the Ugandan subset of the Sub-Saharan African …